Revolution Medicines Inc

Stock Chart, Company Information, and Scan Results

$35(as of Aug 8, 4:00 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Revolution Medicines Inc Company Information, Fundamentals, and Technical Indicators

Stock Price$35
Ticker SymbolRVMD
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees700
CountyUSA
Market Cap$6,542.7M
EBIDTA-890.7M
10-Day Moving Average36.74
P/E Ratio-8.47
20-Day Moving Average37.43
Forward P/E Ratio0.00
50-Day Moving Average38.47
Earnings per Share-4.52
200-Day Moving Average42.08
Profit Margin-Infinity%
RSI36.37
Shares Outstanding186.9M
ATR1.49
52-Week High62.40
Volume3,790,295
52-Week Low29.17
Most Recent Support Level34.00
Book Value2,078.2M
Most Recent Resistance Level38.60
P/B Ratio3.17
Upper Keltner40.79
P/S Ratio25.17
Lower Keltner34.07
Debt-to-Equity Ratio40.79
Next Earnings Date11/05/2025
Cash Surplus175.0M
Next Ex-Dividend DateUnknown

Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.

Revolution Medicines Inc In Our Stock Scanner

As of Aug 11, 2025
example chart graphic
Scan Name: Heikin Ashi BreakoutScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
example chart graphic
Scan Name: Doji CandlesScan Type: Candlestick Pattern Scans
As of ---
example chart graphic
Scan Name: Long Legged DojiScan Type: Candlestick Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.